PDC*line Pharma raises €17.5 million ($20.3M) in Series B2 financing round

Liège, Belgium and Grenoble, France, December 6, 2021 – PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, announces today the completion of its Series B2 round of financing. The company has raised a total of €17.5 million ($20.3M) wit...

Related Keywords

Germany ,Walloon Region ,Waals Gewest ,Belgium ,Seongnam ,Kyonggi Do ,South Korea ,Netherlands ,Wallonia ,Tianma ,Sichuan ,China ,Poland ,France ,Belgian ,Korea ,Chun Yang Hyun ,Aeropole Gosselies ,Sangwoo Lee ,Eric Halioua ,Cognitive Fund ,Alpha Chips Corp ,Regional Investment Company Of Wallonia ,Alpha Holdings ,Alpha Holdings Inc ,Korea Exchange ,Noshaq Group ,Investment Company ,University Of Li ,Hansongneotech Co ,Shinhan Financial Group ,Lg Electronics ,Belgian Federal Holding ,Healthcare Venture Fund ,Lg Energy Solution ,Korea Investment Holdings ,Life Sciences ,Participation Company ,Korea Investment Partners ,Brain Asset Management ,Regional Investment Company ,Smart Korea ,Healthcare Venture ,Korea Investment ,Kun Yung Park ,Fine Metal Mask ,Organic Light Emitting Diode ,Investment Partners ,Shinhan Cognitive Start Up Fund ,Shinhan Investment ,Korean Internet Venture ,Investissement De Wallonie ,Federal Participation Company ,Federal Investment ,